跳至主要内容
临床试验/DRKS00028699
DRKS00028699已完成4 期

Evaluation of medical benefits and positive effects of the certified medical product PINK! Coach in a multi-centre, randomized controlled clinical study with breast cancer patients - PINK! Coach

PINK gegen Brustkrebs GmbH0 个研究点目标入组 434 人开始时间: 2022年8月29日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
434

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • age > 18 years
  • German speaking
  • Histologically proven breast cancer (all stages, TNM classifications, therapies)
  • Diagnosis of the initial disease, recurrence, metastasis within the last 6 months
  • In initial therapy (at least 6 weeks left at the time of recruitment) or discharge for aftercare at the time of recruitment
  • owning a smartphone
  • willingness to use PINK! Coach regularly
  • existence of an e-mail address

排除标准

  • Estimated survival < 3 months
  • Use of another app to accompany cancer therapy or aftercare

研究者

发起方
PINK gegen Brustkrebs GmbH

相似试验